Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation

Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation

Background: Serotherapy with anti-T lymphocyte globulin (ATLG, Grafalon, formerly ATG-Fresenius) is established for the prevention of severe graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT). The evidence from prospective studies is predominantly derived from a se...

Full description

Bibliographic Details
Main Authors: Alexander Nikoloudis, Irene Strassl, Michaela Binder, Olga Stiefel, Dagmar Wipplinger, Robert Milanov, Christoph Aichinger, Emine Kaynak, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Alexandra Böhm, Andreas Petzer, Ansgar Weltermann, Dominik Wolf, David Nachbaur, Johannes Clausen
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Transplantology
Subjects:
ATLG
MTX
MMF
HSCT
Online Access:https://www.mdpi.com/2673-3943/4/1/5

Similar Items

Similar Items